Relationship Between Selected Factors and the Severity of Cervical Cancer in Women

Authors

  • Teabpaluck Sirithanawutichai Faculty of Medicine, Mahasarakham University
  • Kuasit Faculty of Medical, Mahasarakham University
  • Umaporn Kuasit Faculty of Nursing, Mahasarakham University
  • Duangtida Shangyom Faculty of Nursing, Mahasarakham University

Keywords:

Cervical cancer, Severity stages, Selected factors, Parity

Abstract

This retrospective descriptive study aimed to study the relationship between selected factors and the severity of cervical cancer among women. A purposive sample of 116 women diagnosed with cervical cancer for the first time at the Obstetrics and Gynecology Department between 1 May 2015 and 26 June 2019 was recruited. The sample size was determined using the Krejcie and Morgan table, and systematic sampling was employed. Data on cervical cancer stage severity, collected from medical records using a standardized data collection form based on the FIGO 2018 staging system, were analyzed. The Content Validity Index (CVI) was 0.82, and Cronbach's alpha was 0.86. Data were analyzed using descriptive statistics, chi-square test, and Fisher's exact test.

The study found that most participants were aged 40-49 years (30.20%) and were married (96.60%). HIV infection was 1.70%, with 48.30% having 1-2 parity. The majority had early-stage cervical cancer (stage I: IA1-IB3, 45.70%), followed by advanced stages (stage II:
IIA1-IIB, 29.30%; stage III: IIIA-IIIC2, 21.60%; and stage IV: IVA -IVB, 3.40%). A significant positive correlation was found between the parity and the severity of cervical cancer (p< 0.05). Other factors such as age, marital status, HIV infection, and history of oral contraceptive use were not significantly associated with cervical cancer severity (p< 0.05). Therefore, healthcare providers should encourage women with multiple parity or births to undergo regular cervical cancer screening. Additionally, they should provide education and organize activities to raise awareness about risk factors, aiming to reduce the risk and severity of cervical cancer.

References

กชกร ทิพย์สันเทียะ, วิศรุดา ตีเมืองซ้าย, และสุพจน์ คำสะอาด. (2565, 25 มีนาคม). อุบัติการณ์การมาตรวจยืนยันผลพยาธิวิทยาของสตรีที่มีผลการตรวจคัดกรองมะเร็งปากมดลูกผิดปกติ โรงพยาบาลมหาสารคาม จังหวัดมหาสารคาม [เอกสารนำเสนอในที่ประชุม]. การประชุมวิชาการเสนอผลงานวิจัยระดับบัณฑิตศึกษาระดับชาติ ครั้งที่ 23. ขอนแก่น.

วราภรณ์ จันทร์รัตน์. (2567). ความชุกและปัจจัยที่ส่งผลต่อความเสี่ยงโรคมะเร็งปากมดลูกของโรงพยาบาลยางตลาดอำเภอยางตลาด จังหวัดกาฬสินธุ์. วารสารอนามัยสิ่งแวดล้อมและสุขภาพชุมชน, 9(2), 631-639.

สำนักงานสาธารณสุขจังหวัดมหาสารคาม. (2562, 16 พฤศจิกายน). ทะเบียนมะเร็ง จังหวัดมหาสารคาม. https://mkm.hdc.moph.go.th/hdc/main/index.php

อารยา ประเสริฐชัย, และมยุรินทร์ เหล่ารุจิสวัสดิ์. (2566). แนวโน้มอัตราการตายด้วยโรคมะเร็งปากมดลูกในประเทศไทยระหว่างปี พ.ศ.2554-2564. วารสารความปลอดภัยและสุขภาพ, 16(1), 203-217.

อัญชลี ชัยนวล. (2564). ปัจจัยที่สัมพันธ์กับการเกิดความผิดปกติของเซลล์เยื่อบุผิวปากมดลูก และการทำนายโอกาสเกิดรอยโรคปากมดลูกขั้นสูง. วารสารโรงพยาบาลนครพิงค์, 12(2), 19-31.

Asthana, S., Busa, V., & Labani, S. (2020). Oral contraceptives use and risk of cervical cancer—A systematic review & meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 247, 163-175. https://doi.org/10.1016/j.ejogrb.2020.02.014

Frida, K. M., Atieno, W. M. C., & Habtu, M. (2017). Socio-demographic factors associated with advanced stage of cervical cancer at diagnosis in Kenyatta National Hospital, Kenya: A cross sectional study. Journal of Cancer Science & Therapy, 9(7), 554-561. DOI:10.4172/1948-5956.1000473

Guo, C., Zhan, B., Li, M.-Y., Yue, L., & Zhang, C. (2024). Association between oral contraceptives and cervical cancer: A retrospective case–control study based on the National Health and Nutrition Examination Survey. Frontiers in Pharmacology, 15, 1400667. https://doi.org/10.3389/fphar.2024.1400667

Krejcie, R. V., & Morgan, D. W. (1970). Determining sample size for research activities. Educational and Psychological Measurement, 30(3), 607-610.

Kusuma, F., Suryoadji, K. A., Adrian, M., Utami, T. W., Winarto, H., Anggraeni, T. D., Nuryanto, K. H., & Haekal, M. (2022). Socio-demographic profiles of cervical cancer patients at cipto mangunkusumo hospital-2009-2019 and its association with cancer stages at diagnosis. Cermin Dunia Kedokteran, 49(5), 245-247. https://doi.org/10.55175/cdk.v49i5.227

Mattern, J., Letendre, I., Sibiude, J., Pénager, C., Jnifen, A., Souare, F., Ayel, S., Nguyen, T., & Mandelbrot, L. (2022). Diagnosis of advanced cervical cancer, missed opportunities? BMC Women's Health, 22(1), 97. https://doi.org/10.1186/s12905-022-01668-3

Momenimovahed, Z., & Salehiniya, H. (2017). Incidence, mortality and risk factors of cervical cancer in the world. Biomedical Research and Therapy, 4(12), 1795-1811. https://doi.org/10.15419/bmrat.v4i12.386

Rani, R., Kumar, R., Trivedi, V., Singh, U., Chauhan, R., Ali, M., & Kumar, A. (2016). Age, parity and stages of cervix cancer: A hospital based study. British Journal of Medical and Health Research, 3(4), 73-82.

Rojanamatin, J., Ukranun, W., Supaattagorn, P., Chiawiriyabunya, I., Wongsena, M. C., Chaiwerawattana, A., Laowahutanont, P., Chitapanarux, I., Vatanasapt, P., & Greater, S. (Eds.). (2021). Cancer in Thailand Vol. X, 2016-2018. Medical Record and Databased Cancer Unit, Medical Digital Division, National Cancer Institute.

Salib, M. Y., Russell, J. H., Stewart, V. R., Sudderuddin, S. A., Barwick, T. D., Rockall, A. G., & Bharwani, N. (2020). 2018 FIGO staging classification for cervical cancer: Added benefits of imaging. Radiographics, 40(6), 1807-1822. https://doi.org/10.1148/rg.2020200013

Savrova, A., Jaal, J., Nomm, O., & Innos, K. (2023). Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: A population-based study. Public Health, 225, 369-375. https://doi.org/10.1016/j.puhe.2023.10.025

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660

Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720-728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05

Downloads

Published

2024-12-20

How to Cite

Sirithanawutichai, T. ., Kuasit , T. ., Kuasit, U. ., & Shangyom, D. . (2024). Relationship Between Selected Factors and the Severity of Cervical Cancer in Women. Journal of Boromarajonani College of Nursing, Surin, 14(2), 29–41. retrieved from https://he01.tci-thaijo.org/index.php/bcnsurin/article/view/271668

Issue

Section

Research Article